Search

Search Constraints

You searched for: Author/Creator Baird, Alison L.

Search Results

1. [F1–02–02]: DISCOVERY AND VALIDATION OF MULTIMODAL BIOMARKER SIGNATURES RELATING TO ALZHEIMER'S DISEASE PATHOLOGY AND PROGRESSION. (1st July 2017)

2. [P1–289]: DISCOVERY, REPLICATION AND EXTENSION STUDY OF PLASMA PROTEOMIC BIOMARKERS RELATING TO BRAIN AMYLOID BURDEN (CSF Aβ OR AMYLOID‐PET) IN THE EMIF‐AD BIOMARKER DISCOVERY COHORT. (1st July 2017)

3. [P2–212]: EUROPEAN MEDICAL INFORMATION FRAMEWORK FOR ALZHEIMER's DISEASE (EMIF‐AD): THE BIOMARKER DISCOVERY STUDY. (1st July 2017)

5. Blood protein predictors of brain amyloid for enrichment in clinical trials?. Issue 1 (1st March 2015)

6. Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay. Issue 11 (5th September 2019)

7. F1‐02‐01: RELATING CSF MARKERS NEUROGRANIN, NEUROFILAMENT‐LIGHT AND YKL‐40 TO Aβ, APOE ε4 AND COGNITION: RESULTS FROM THE EMIF‐AD MULTIMODAL BIOMARKER DISCOVERY STUDY. (1st July 2006)

8. F1‐02‐02: DISCOVERY, REPLICATION AND EXTENSION STUDY OF PLASMA PROTEOMIC BIOMARKERS RELATING TO BRAIN AMYLOID BURDEN AND ALZHEIMER'S DISEASE PROGRESSION. (1st July 2006)

9. F1‐02‐03: MRI PREDICTORS OF AMYLOID PATHOLOGY: RESULTS FROM THE EMIF‐AD BIOMARKER DISCOVERY STUDY. (1st July 2006)

10. F1‐02‐04: GENOMICS AND EPIGENOMICS ANALYSES IN THE EMIF‐AD MULTIMODAL BIOMARKER DISCOVERY STUDY. (1st July 2006)